Teva Pharmaceutical Industries A TEVA
Stock price quote for Teva Pharmaceutical Industries A, symbol TEVA, New York Stock Exchange.
Quote data is updated continously during trading hours.
Teva Pharmaceutical Industries A Symbol: TEVA Exchange: NYSE
|
Most Recent Activity |
Activity Today |
Yearly Statistics |
|
|
|
NYSE prices delayed 20 minutes.
Stock price quotations are updated continuously. Click reload to refresh this display.
[Daily],
[Weekly]
and [Monthly] stock price charts are available for Teva Pharmaceutical Industries A
Most Recent HeadlinesBIZ: Apr 16th, 2024, 17:43Length: 24546 Alvotech and Teva Announce U.S. FDA Approval of SELARSDI(TM) (ustekinumab-aekn), biosimilar to Stelara(R) (ustekinumab)
BIZ: Apr 16th, 2024, 08:00Length: 14202 Teva's New Real-World Evidence Presented at the 2024 AAN Annual Meeting Confirms Effectiveness and Patient Satisfaction for HD Chorea with the 4-week Titration Kit for AUSTEDO(R) (deutetrabenazine) Tablets
BIZ: Apr 11th, 2024, 08:30Length: 10295 Teva Confirms Efficacy and Safety of AJOVY(R) (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China
BIZ: Apr 9th, 2024, 16:30Length: 3730 Teva to Host Conference Call to Discuss First Quarter 2024 Financial Results at 8 a.m. ET on May 8, 2024
BIZ: Apr 6th, 2024, 13:00Length: 31104 New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY(R) (risperidone) Extended-Release Injectable Suspension at SIRS 2024
BIZ: Apr 4th, 2024, 08:30Length: 7657 Teva and mAbxience Announce Strategic Global Licensing Agreement for Oncology Biosimilar Candidate
Market data delivered to TradingCharts.com, Inc. by Barchart.com.
Although it is believed that information provided is accurate, no guarantee is made.
|